🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
China flag China · Delayed Price · Currency is CNY
26.31
-0.12 (-0.45%)
Nov 20, 2026, 3:00 PM CST

SHA:600993 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
594.83581.49528.09443.25478.57464.59
Depreciation & Amortization
85.7985.798180.5678.5168.57
Other Amortization
12.5812.585.649.529.839.22
Loss (Gain) From Sale of Assets
0.090.09-0.02-5.650.290.79
Asset Writedown & Restructuring Costs
7.417.415.40.090.060.15
Loss (Gain) From Sale of Investments
-33.85-33.85-13.81-91.91-2.86-54.31
Provision & Write-off of Bad Debts
5.65.68.273.939.933.06
Other Operating Activities
217.2533.9830.6335.3618.5226.47
Change in Accounts Receivable
-191.45-191.45-193.98148.03-356.2231.67
Change in Inventory
-44.36-44.36-8.755.32-26.26-46.37
Change in Accounts Payable
148.52148.5261.32-75.45137.86-105.32
Change in Other Net Operating Assets
----1.12-0.77-0.32
Operating Cash Flow
797.04600.44497.61604.07341.85597.17
Operating Cash Flow Growth
26.49%20.66%-17.62%76.70%-42.75%111.02%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-106.45-119.37-203.85-248.36-75.01-65.1
Sale of Property, Plant & Equipment
0.40.50.923.610.460.58
Divestitures
0.450.45--0.56-4
Investment in Securities
-1,203-743.36-60.72675.91-574.13-36.59
Other Investing Activities
00.07-17.6829.9234.07
Investing Cash Flow
-1,309-861.72-263.65448.27-618.76-63.05

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-----78
Long-Term Debt Issued
-1444.658.6488.31-
Total Debt Issued
-1444.658.6488.3178
Short-Term Debt Repaid
------123
Long-Term Debt Repaid
--186.27-91.91-429.95-127.47-32.81
Lease Payments
-29.82-29.82-31.31-38.84-39.26-32.81
Total Debt Repaid
-57.68-186.27-91.91-429.95-127.47-155.81
Net Debt Issued (Repaid)
-57.68-172.27-47.31-371.35360.84-77.81
Common Dividends Paid
-302.2-269.65-177.28-162.71-165.04-124.5
Other Financing Activities
-41.69-39.46-50.74-45.1-17.6232.66
Financing Cash Flow
-401.57-481.38-275.33-579.16178.18-169.64

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.78-0.20.240.261.24-0.6
Net Cash Flow
-913.9-742.87-41.13473.43-97.49363.88

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
690.59481.07293.76355.7266.84532.07
Free Cash Flow Growth
26.50%63.76%-17.41%33.30%-49.85%123.96%
Free Cash Flow Margin
17.31%12.44%7.88%11.34%7.55%15.72%
Free Cash Flow Per Share
1.611.120.680.830.621.24
Levered Free Cash Flow
394.9774.41191.59129.78263.3281.25
Unlevered Free Cash Flow
398.0579.02196.2140.32270.61287.63
Free Cash Flow After Leases
660.77451.25262.45316.86227.58499.27

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
362.35310.83328.43323.88308.24288.92
Change in Working Capital
-92.66-92.66-147.61128.91-25178.63